Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MiNK Therapeutics, Inc. - Common Stock (NQ:INKT)

11.87 +0.21 (+1.80%)

Streaming Delayed Price Updated: 1:52 PM EST, Dec 23, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	8,284
Open	11.33
Bid (Size)	11.65 (1,000)
Ask (Size)	11.96 (100)
Prev. Close	11.66
Today's Range	11.33 - 11.98
52wk Range	4.560 - 76.00
Shares Outstanding	34,422,063
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors

November 20, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics (INKT) Earnings Call Transcript ↗

November 14, 2025

MiNK Therapeutics (INKT) Earnings Call Transcript

Via The Motley Fool

Performance

YTD	+17.5%	+17.5%
1 Month	+7.7%	+7.7%
3 Month	-27.2%	-27.2%
6 Month	+58.7%	+58.7%
1 Year	+141.7%	+141.7%

More News

MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

November 14, 2025

From MiNK Therapeutics

Via GlobeNewswire

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Earnings Scheduled For November 14, 2025 ↗

November 14, 2025

Via Benzinga

MiNK Therapeutics's Earnings Outlook ↗

November 13, 2025

Via Benzinga

MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025

November 07, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development

November 05, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting

October 30, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, to Board of Directors

September 29, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA

September 25, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development

September 18, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics Extends Cash Runway ↗

August 14, 2025

Via The Motley Fool

MiNK INKT Q2 2025 Earnings Call Transcript ↗

August 14, 2025

Via The Motley Fool

MiNK Therapeutics Inc (NASDAQ:INKT) Reports Wider Q2 2025 Loss, Advances Clinical Pipeline Amid Market Caution ↗

August 14, 2025

Via Chartmill

MiNK Therapeutics Cuts Q2 Cash Use 31% ↗

August 14, 2025

Via The Motley Fool

MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results

August 14, 2025

From MiNK Therapeutics

Via GlobeNewswire

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

July 31, 2025

From MiNK Therapeutics

Via GlobeNewswire

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

July 17, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 15, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

July 15, 2025

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

July 15, 2025

Via Chartmill

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 15, 2025

Via Benzinga

MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy

July 15, 2025

From MiNK Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 15, 2025

Via Benzinga

Frequently Asked Questions

Is MiNK Therapeutics, Inc. - Common Stock publicly traded?

Yes, MiNK Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does MiNK Therapeutics, Inc. - Common Stock trade on?

MiNK Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for MiNK Therapeutics, Inc. - Common Stock?

The ticker symbol for MiNK Therapeutics, Inc. - Common Stock is INKT on the Nasdaq Stock Market

What is the current price of MiNK Therapeutics, Inc. - Common Stock?

The current price of MiNK Therapeutics, Inc. - Common Stock is 11.87

When was MiNK Therapeutics, Inc. - Common Stock last traded?

The last trade of MiNK Therapeutics, Inc. - Common Stock was at 12/23/25 01:52 PM ET

What is the market capitalization of MiNK Therapeutics, Inc. - Common Stock?

The market capitalization of MiNK Therapeutics, Inc. - Common Stock is 408.59M

How many shares of MiNK Therapeutics, Inc. - Common Stock are outstanding?

MiNK Therapeutics, Inc. - Common Stock has 409M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.